Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn’s Disease

被引:0
作者
Sundaram G. Veerappan
Martin Healy
Bernard J. Walsh
Colm A. O’Morain
Jacqueline S. Daly
Barbara M. Ryan
机构
[1] Royal College of Surgeons in Ireland,Division of Biology, Department of Anatomy
[2] Adelaide and Meath Hospital,Department of Gastroenterology
[3] St. James’s Hospital,Department of Biochemistry
[4] St. James’s Hospital,Department of Gerontology
来源
Digestive Diseases and Sciences | 2015年 / 60卷
关键词
Adalimumab; Crohn’s disease; Osteoporosis; Bone metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2119 / 2129
页数:10
相关论文
共 117 条
[1]  
Genant HK(1976)Skeletal demineralization and growth retardation in inflammatory bowel disease Invest Radiol 11 541-549
[2]  
Mall JC(1997)Reduced bone density in patients with inflammatory bowel disease Gut 40 228-233
[3]  
Wagonfeld JB(1998)Femoral neck osteopenia in patients with inflammatory bowel disease Am J Gastroenterol 93 1483-1490
[4]  
Horst JV(2004)Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study Gut 53 251-255
[5]  
Lanzi LH(1995)A controlled study of bone mineral density in patients with inflammatory bowel disease Gut 37 71-76
[6]  
Bjarnasson I(2002)Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease Aliment Pharmacol Ther 16 1895-1902
[7]  
Macpherson A(1997)Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency J Clin Invest 99 1699-1703
[8]  
Mackintosh C(1999)Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis Rheumatology (Oxford) 38 841-847
[9]  
Buxton-Thomas M(1991)Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease Gut 32 913-917
[10]  
Forgacs I(2001)Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR Clin Chem 47 1297-1301